Trial Profile
Phase III study of safety of meningococcal vaccine group A conjugate (MenAfriVac) in healthy Malians
Status:
Completed
Phase of Trial:
Phase III
Latest Information Update: 16 Nov 2015
Price :
$35
*
At a glance
- Drugs Meningococcal vaccine group A conjugate (Primary) ; Meningococcal vaccine groups A C Y W-135 conjugate
- Indications Meningococcal group A infections
- Focus Adverse reactions; Registrational
- Sponsors PATH
- 16 Nov 2015 New trial record
- 15 Nov 2015 Results published in the Clinical Infectious Diseases